Rothwell Investment Advisors, LLC’s BioNTech BNTX Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.18K	Buy	+73	New	+$7.09K	﹤0.01%	834

Other funds holding BNTX

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

GSK plc London $497M AUM 35.1% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

LBP AM Paris, France $11.2B AUM 34.48% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

Rothwell Investment Advisors, LLC's BNTX Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in BioNTech (BNTX) in Q3 2026: 73 shares worth $7.18K. The stake represents ﹤0.01% of the portfolio and ranks #834 among its holdings.

113 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

Rothwell Investment Advisors, LLC held 73 shares of BioNTech worth $7.18K as of Q3 2026.
BioNTech was a new Rothwell Investment Advisors, LLC position in Q3 2026.
BioNTech made up ﹤0.01% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #834 holding.
113 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.